Disrupted and Elevated Circadian Secretion of Glucagon-Like Peptide-1 in a Murine Model of Type 2 Diabetes
Endocrinology · 01.09.2022 · 163 (9)
DOI: 10.1210/endocr/bqac118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 25.07.2022. Verfasst von Andrew D Biancolin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Physiology, University of Toronto, Toronto ON M5S 1A8, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Canadian Institutes of Health Research, Canadian Foundation for Innovation and Ontario Research Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Metabolism and circadian rhythms are intimately linked, with circadian glucagon-like peptide-1 (GLP-1) secretion by the intestinal L-cell entraining rhythmic insulin release. GLP-1 secretion has been explored in the context of obesogenic diets, but never in a rodent model of type 2 diabetes (T2D). There is also considerable disagreement regarding GLP-1 levels in human T2D. Furthermore, recent evidence has demonstrated decreased expression of the β-cell exocytotic protein secretagogin (SCGN) in T2D. To extend these findings to the L-cell, we administered oral glucose tolerance tests at 6 time points in 4-hour intervals to the high-fat diet/streptozotocin (HFD-STZ) mouse model of T2D. This revealed a 10-fold increase in peak GLP-1 secretion with a phase shift of the peak from the normal feeding period into the fasting-phase. This was accompanied by impairments in the rhythms of glucose, glucagon, mucosal clock genes (Arntl and Cry2), and Scgn. Immunostaining revealed that L-cell GLP-1 intensity was increased in the HFD-STZ model, as was the proportion of L-cells that expressed SCGN; however, this was not found in L-cells from humans with T2D, which exhibited decreased GLP-1 staining but maintained their SCGN expression. Gcg expression in isolated L-cells was increased along with pathways relating to GLP-1 secretion and electron transport chain activity in the HFD-STZ condition. Further investigation into the mechanisms responsible for this increase in GLP-1 secretion may give insights into therapies directed toward upregulating endogenous GLP-1 secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Physiology, University of Toronto, Toronto ON M5S 1A8, Canada.
- Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada.
ORCID-Profile: Patricia L Brubaker
Förderung
- CIHR
- Canadian Institutes of Health Research
- Canadian Foundation for Innovation and Ontario Research Fund
Zitieren
APA
Biancolin, A. D., Jeong, H., Mak, K. W. Y., Yuan, Z., & Brubaker, P. L. (2022). Disrupted and Elevated Circadian Secretion of Glucagon-Like Peptide-1 in a Murine Model of Type 2 Diabetes. Endocrinology, 163(9). https://doi.org/10.1210/endocr/bqac118
Vancouver
Biancolin AD, Jeong H, Mak KWY, Yuan Z, Brubaker PL. Disrupted and Elevated Circadian Secretion of Glucagon-Like Peptide-1 in a Murine Model of Type 2 Diabetes. Endocrinology. 2022;163(9). doi:10.1210/endocr/bqac118
BibTeX
@article{Biancolin2022,
author = {Biancolin, Andrew D and Jeong, Hyerin and Mak, Kimberly W Y and Yuan, Zixuan and Brubaker, Patricia L},
title = {Disrupted and Elevated Circadian Secretion of Glucagon-Like Peptide-1 in a Murine Model of Type 2 Diabetes},
journal = {Endocrinology},
year = {2022},
volume = {163},
number = {9},
doi = {10.1210/endocr/bqac118}
}
EUVIMED